ICU Medical, Inc. (NASDAQ:ICUI) Shares Sold by F M Investments LLC

F M Investments LLC lowered its holdings in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 61.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 26,624 shares of the medical instruments supplier's stock after selling 42,777 shares during the period. F M Investments LLC owned about 0.11% of ICU Medical worth $4,131,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in ICUI. Harvest Fund Management Co. Ltd bought a new position in shares of ICU Medical in the fourth quarter worth approximately $33,000. Murphy & Mullick Capital Management Corp bought a new position in shares of ICU Medical during the fourth quarter valued at approximately $52,000. Venturi Wealth Management LLC lifted its position in shares of ICU Medical by 64.0% during the fourth quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier's stock valued at $82,000 after buying an additional 206 shares during the last quarter. Russell Investments Group Ltd. raised its holdings in shares of ICU Medical by 88.8% in the fourth quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier's stock worth $99,000 after buying an additional 300 shares during the last quarter. Finally, Smartleaf Asset Management LLC raised its stake in shares of ICU Medical by 166.8% during the 4th quarter. Smartleaf Asset Management LLC now owns 907 shares of the medical instruments supplier's stock valued at $140,000 after buying an additional 567 shares during the last quarter. Hedge funds and other institutional investors own 96.10% of the company's stock.

ICU Medical Stock Performance

Shares of ICUI traded up $0.43 during mid-day trading on Wednesday, hitting $140.07. 25,345 shares of the company traded hands, compared to its average volume of 268,331. The stock has a market cap of $3.43 billion, a price-to-earnings ratio of -30.65 and a beta of 0.86. ICU Medical, Inc. has a 1 year low of $93.36 and a 1 year high of $196.26. The stock has a 50-day moving average price of $147.50 and a two-hundred day moving average price of $160.47. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the company. Raymond James set a $97.00 target price on ICU Medical in a research note on Wednesday, March 12th. Needham & Company LLC reissued a "hold" rating on shares of ICU Medical in a research note on Tuesday, April 8th. Finally, StockNews.com upgraded shares of ICU Medical from a "hold" rating to a "buy" rating in a research report on Wednesday. One investment analyst has rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, ICU Medical has an average rating of "Buy" and a consensus target price of $168.67.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.